Alpha Fetoprotein, CSF (Tumor Marker) AFPCSF

Synonyms

Allscripts (AEHR) Order Name

Alpha Fetoprotein, CSF (Tumor Marker)

Sunrise Clinical Manager (SCM) Order Name

Alpha Fetoprotein, CSF (Tumor Marker)

EPIC Order Name

Alpha Fetoprotein, CSF (Tumor Marker)

Clinical Info

AFP is a valuable aid in the management of nonseminomatous testicular cancer patients when used in conjunction with information available
from the clinical evaluation and other diagnostic procedures. Increased AFP concentrations have also been observed in ataxia telangiectasia,
hereditary tyrosinemia, primary hepatocellular carcinoma, teratocarcinoma, gastrointestinal tract cancers with and without liver metastases,
and in benign hepatic conditions such as acute viral hepatitis, chronic active hepatitis, and cirrhosis. The result cannot be interpreted as 
absolute evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females.

Specimen Type

CSF

Specimen Volume

0.5 mL CSF to Plastic Standard Transport Tube. (Min: 0.2 mL)

Container

CSF in Standard Plastic Transport Tube

Collection Instructions

0.5 mL CSF to Plastic Standard Transport Tube. (Min: 0.2 mL)

Transport Instructions

Refrigerated Temperature

Specimen Stability

Room Temperature: 3 days
Refrigerated: 2 weeks
Frozen: 1 year

Methodology

Quantitative Chemiluminescent Immunoassay

Days Performed

TAT: 2-3 Days

Performing Laboratories

ARUP Laboratories

CPT

86316

PDM

255102

Result Interpretation

Forms